Fully funded by Bioheart, the trial is being conducted in Mexico at the Hospital Angeles in conjunction with the Regenerative Medicine Institute .
http://www.marketwired.com/press-release/bioheart-announces-positive-preliminary-data-from-phase-i-angel-trial-otcqb-bhrt-1835253.htm
http://www.marketwired.com/press-release/bioheart-announces-positive-preliminary-data-from-phase-i-angel-trial-otcqb-bhrt-1835253.htm
No comments:
Post a Comment